CA Compounds
CJC-1295 (No DAC) + Ipamorelin 5/5mg
$75.00
🔒 Secure Checkout
All payments are processed securely through Burner Pay.
*NOT FOR HUMAN CONSUMPTION*
Product Usage: THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only.
A research blend pairing CJC-1295 No DAC (modified GRF 1-29) with Ipamorelin for studies of GHRH- and ghrelin-receptor signaling and pulsatile growth-hormone pathway biology.
DISCLAIMER
All products sold by California Compounds are intended strictly for laboratory and research use only.
- Not for human consumption
- Not for medical or therapeutic use
- Not approved by regulatory authorities
By purchasing, you confirm you are 18+ and authorised to use this product for lawful research purposes only.
Buy CJC-1295 No DAC + Ipamorelin 5/5mg Research Blend
CJC-1295 (No DAC) + Ipamorelin combines two research peptides that engage different upstream pathways associated with growth-hormone signaling. CJC-1295 No DAC, commonly identified as modified GRF(1-29), is studied through growth hormone-releasing hormone receptor pathways, while Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist used in growth-hormone secretagogue research. The blend is useful for laboratory work examining receptor cross-talk, pulsatile endocrine signaling, and downstream GH/IGF-axis biology. Arizona’s current COA identifies the CJC component as No DAC, so the California title should be updated only after the vial label is confirmed.
Research focus:
• GHRH-receptor signaling
• Ghrelin receptor / GHS-R1a signaling
• Pulsatile endocrine-pathway models
• GH/IGF-axis research
Format: 5mg CJC-1295 No DAC + 5mg Ipamorelin research blend, subject to label confirmation
For laboratory research use only. Not for human consumption. Not intended for diagnostic, therapeutic, or veterinary use.
